RPT: Carl Zeiss Meditec AG: Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution

About this update from Carl Zeiss Meditec Ag

EQS Related Party Transactions announcement: Carl Zeiss Meditec AG / Release of an announcement according to Article 111c of the AktG [the German Stock Corporation Act] Carl Zeiss Meditec AG: Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution 12.05.2026 / 09:00 CET/CEST Dissemination of a Related Party Transactions announcement transmitted by EQS News - a service of EQS Group . The issuer is solely responsible for the content of this announcement. Carl Zeiss Meditec AG Jena  ISIN: DE 0005313704 Disclosure of transactions with related parties pursuant to Section 111c (2) of the German Stock Corporation Act   Carl Zeiss Meditec AG (the " Company ") hereby discloses, pursuant to Section 111c (2) of the German Stock Corporation Act (AktG), the transactions described below with Carl Zeiss AG, Oberkochen, as a related party within the meaning of Section 111a (1) Sentence 2 of the AktG. On 12 May 2026, the Management Board of the Company resolved to enter into a lease agreement with Carl Zeiss AG for the future headquarters at the Jena site ("Jena high-tech site") based on the following key terms and conditions: The base rent amounts to €8.8m per year and shall be paid by the Company starting from the 2027/28 fiscal year. Including the existing production facilities that will continue to be used, the Company's total lease expenses towards Carl Zeiss AG will increase from approximately EUR 2 million in fiscal year 2024/25 to approximately EUR 10 million per year from fiscal year 2027/28. On this basis, the lease agreement is now to be finalized and concluded shortly thereafter. Furthermore, on 12 May 2026, Carl Zeiss Meditec AG and Carl Zeiss AG reached an agreement regarding an increase in costs for passing on additional costs for services provided within the Group. These include, in particular, IT, HR and other shared services, for which the ZEISS Group has incurred considerable additional expenses in recent years due to wage inflation and increased infrastructure costs. The total annual expense charged to the Company for these services will increase in three steps by a total of approximately EUR 30 million starting in the current 2025/26 fiscal year and continuing through the 2028/29 fiscal year. The aforementioned agreements constitute transactions with related parties within the meaning of section 111a et seq. of the German Stock Corporation Act (AktG). Carl Zeiss AG, based in Oberkochen, as the parent company, holds the majority of voting rights in Carl Zeiss Meditec AG and therefore constitutes a related party within the meaning of Section 111a (1) Sentence 2 of the German Stock Corporation Act (AktG). The Supervisory Board of Carl Zeiss Meditec AG approved the aforementioned transactions in accordance with Section 111b (1) German Stock Corporation Act (AktG) on 8 May 2026 and authorized the Management Board to conclude the corresponding transactions. Jena, 12 May 2026 Carl Zeiss Meditec AG The Management Board 12.05.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News Language: English Company: Carl Zeiss Meditec AG Göschwitzer Str. 51-52 07745 Jena, Germany Germany Internet: www.zeiss.de/meditec-ag/ir   End of News EQS News Service 2325732  12.05.2026 CET/CEST

View stock analysis, news, and events for Carl Zeiss Meditec Ag